Skip to main content
Erschienen in: Neurological Sciences 3/2016

01.03.2016 | Original Article

Determination of arylsulfatase A pseudodeficiency allele and haplotype frequency in the Tunisian population

verfasst von: Nizar Ben Halim, Imen Dorboz, Rym Kefi, Najla Kharrat, Eleonore Eymard-Pierre, Majdi Nagara, Lilia Romdhane, Nissaf Ben Alaya-Bouafif, Ahmed Rebai, Najoua Miladi, Odile Boespflug-Tanguy, Sonia Abdelhak

Erschienen in: Neurological Sciences | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Arylsulfatase A (ASA) is a lysosomal enzyme involved in the catabolism of cerebroside sulfate. ASA deficiency is associated with metachromatic leukodystrophy (MLD). Low ASA activities have also been reported in a more common condition with no apparent clinical consequences termed ASA pseudo-deficiency (ASA-PD) which is associated with two linked mutations in the ASA gene (c.1049A>G and c.*96A>G). This study aimed to investigate the frequency of the two ASA-PD variants and their linkage disequilibrium (LD) among Tunisians. ASA-PD variants were detected in 129 healthy Tunisians and their frequencies were compared to those described worldwide. The frequency of the PD allele was estimated at 17.4 % for the overall sample, with c.1049A>G and c.*96A>G frequencies of 25.6 and 17.4 %, respectively. This study also revealed a high LD between the two ASA-PD variants (r 2 = 0.61). Inter-population analysis revealed similarities in the ASA-PD genetic structure between Tunisians and populations from Middle East with c.*96A>G frequencies being the highest in the world. A significant North vs. South genetic differentiation in the ASA-PD frequency was also observed in Tunisian population who seems genetically intermediate between Africans, Middle-Easterners and Europeans. This is the first report on the allele frequency of the ASA-PD in North Africa, revealing a relatively high frequency of the PD allele among Tunisians. This study gives also evidence on the importance of discriminating ASA-PD allele from pathological mutations causing MLD and supporting enzymatic activity testing with both sulfatiduria determination and genetic testing in the differential diagnosis of MLD in the Tunisian population.
Literatur
1.
Zurück zum Zitat Kreysing J, von Figura K, Gieselmann V (1990) Structure of the arylsulfatase A gene. Eur J Biochem 191(3):627–631CrossRefPubMed Kreysing J, von Figura K, Gieselmann V (1990) Structure of the arylsulfatase A gene. Eur J Biochem 191(3):627–631CrossRefPubMed
2.
Zurück zum Zitat Kolodny EH, Fluharty AL (1995) Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York Kolodny EH, Fluharty AL (1995) Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York
3.
Zurück zum Zitat Gieselmann V, Polten A, Kreysing J, von Figura K (1989) Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. Proc Natl Acad Sci USA 86(23):9436–9440CrossRefPubMedPubMedCentral Gieselmann V, Polten A, Kreysing J, von Figura K (1989) Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. Proc Natl Acad Sci USA 86(23):9436–9440CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Barth ML, Ward C, Harris A, Saad A, Fensom A (1994) Frequency of arylsulphatase A pseudodeficiency associated mutations in a healthy population. J Med Genet 31(9):667–671CrossRefPubMedPubMedCentral Barth ML, Ward C, Harris A, Saad A, Fensom A (1994) Frequency of arylsulphatase A pseudodeficiency associated mutations in a healthy population. J Med Genet 31(9):667–671CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Pedron CG, Gaspar PA, Giugliani R, Pereira ML (1999) Arylsulfatase A pseudodeficiency in healthy Brazilian individuals. Braz J Med Biol Res 32(8):941–945 pii:S0100-879X(99)03200802 CrossRefPubMed Pedron CG, Gaspar PA, Giugliani R, Pereira ML (1999) Arylsulfatase A pseudodeficiency in healthy Brazilian individuals. Braz J Med Biol Res 32(8):941–945 pii:S0100-879X(99)03200802 CrossRefPubMed
6.
Zurück zum Zitat Cui Y, Colsch B, Afonso C, Baumann N, Tabet JC, Mallet JM, Zhang Y (2008) Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies. Glycoconj J 25(2):147–155. doi:10.1007/s10719-007-9067-7 CrossRefPubMed Cui Y, Colsch B, Afonso C, Baumann N, Tabet JC, Mallet JM, Zhang Y (2008) Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies. Glycoconj J 25(2):147–155. doi:10.​1007/​s10719-007-9067-7 CrossRefPubMed
7.
Zurück zum Zitat Whitfield PD, Sharp PC, Johnson DW, Nelson P, Meikle PJ (2001) Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry. Mol Genet Metab 73(1):30–37. doi:10.1006/mgme.2001.3165 CrossRefPubMed Whitfield PD, Sharp PC, Johnson DW, Nelson P, Meikle PJ (2001) Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry. Mol Genet Metab 73(1):30–37. doi:10.​1006/​mgme.​2001.​3165 CrossRefPubMed
8.
Zurück zum Zitat Ott R, Waye JS, Chang PL (1997) Evolutionary origins of two tightly linked mutations in arylsulfatase-A pseudodeficiency. Hum Genet 101(2):135–140CrossRefPubMed Ott R, Waye JS, Chang PL (1997) Evolutionary origins of two tightly linked mutations in arylsulfatase-A pseudodeficiency. Hum Genet 101(2):135–140CrossRefPubMed
10.
Zurück zum Zitat Zlotogora J, Furman-Shaharabani Y, Goldenfum S, Winchester B, von Figura K, Gieselmann V (1994) Arylsulfatase A pseudodeficiency: a common polymorphism which is associated with a unique haplotype. Am J Med Genet 52(2):146–150. doi:10.1002/ajmg.1320520205 CrossRefPubMed Zlotogora J, Furman-Shaharabani Y, Goldenfum S, Winchester B, von Figura K, Gieselmann V (1994) Arylsulfatase A pseudodeficiency: a common polymorphism which is associated with a unique haplotype. Am J Med Genet 52(2):146–150. doi:10.​1002/​ajmg.​1320520205 CrossRefPubMed
11.
Zurück zum Zitat Weir BS (1996) Data analysis II. Sinauer Associates, Sunderland Weir BS (1996) Data analysis II. Sinauer Associates, Sunderland
13.
Zurück zum Zitat Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296(5576):2225–2229. doi:10.1126/science.1069424 CrossRefPubMed Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296(5576):2225–2229. doi:10.​1126/​science.​1069424 CrossRefPubMed
14.
Zurück zum Zitat Sangiorgi S, Ferlini A, Zanetti A, Mochi M (1991) Reduced activity of arylsulfatase A and predisposition to neurological disorders: analysis of 140 pediatric patients. Am J Med Genet 40(3):365–369. doi:10.1002/ajmg.1320400324 CrossRefPubMed Sangiorgi S, Ferlini A, Zanetti A, Mochi M (1991) Reduced activity of arylsulfatase A and predisposition to neurological disorders: analysis of 140 pediatric patients. Am J Med Genet 40(3):365–369. doi:10.​1002/​ajmg.​1320400324 CrossRefPubMed
15.
Zurück zum Zitat Tinuper P, Plazzi G, Monari L, Sangiorgi S, Pellissier JF, Cerullo A, Provini F, Capellari S, Baruzzi A, Lugaresi E et al (1994) Arylsulfatase A pseudodeficiency and Lafora bodies in a patient with progressive myoclonic epilepsy. Epilepsia 35(2):332–335CrossRefPubMed Tinuper P, Plazzi G, Monari L, Sangiorgi S, Pellissier JF, Cerullo A, Provini F, Capellari S, Baruzzi A, Lugaresi E et al (1994) Arylsulfatase A pseudodeficiency and Lafora bodies in a patient with progressive myoclonic epilepsy. Epilepsia 35(2):332–335CrossRefPubMed
16.
Zurück zum Zitat Marcao A, Pinto E, Rocha S, Sa Miranda MC, Ferreira L, Amaral O (2003) ARSA-PD associated alleles in the Portuguese population: frequency determination and haplotype analysis. Mol Genet Metab 79(4):305–307 pii:S1096719203000921 CrossRefPubMed Marcao A, Pinto E, Rocha S, Sa Miranda MC, Ferreira L, Amaral O (2003) ARSA-PD associated alleles in the Portuguese population: frequency determination and haplotype analysis. Mol Genet Metab 79(4):305–307 pii:S1096719203000921 CrossRefPubMed
17.
Zurück zum Zitat Philpot M, Lewis K, Pereria ML, Ward C, Holmes C, Lovestone S, Fensom A, Seller M (1997) Arylsulphatase A pseudodeficiency in vascular dementia and Alzheimer’s disease. Neuroreport 8(11):2613–2616CrossRefPubMed Philpot M, Lewis K, Pereria ML, Ward C, Holmes C, Lovestone S, Fensom A, Seller M (1997) Arylsulphatase A pseudodeficiency in vascular dementia and Alzheimer’s disease. Neuroreport 8(11):2613–2616CrossRefPubMed
18.
Zurück zum Zitat Ameur A (1960) La Tunisie à travers l’histoire (Arab version) Ameur A (1960) La Tunisie à travers l’histoire (Arab version)
19.
Zurück zum Zitat Athanasiadis G, Esteban E, Via M, Dugoujon JM, Moschonas N, Chaabani H, Moral P (2007) The X chromosome Alu insertions as a tool for human population genetics: data from European and African human groups. Eur J Hum Genet 15(5):578–583. doi:10.1038/sj.ejhg.5201797 CrossRefPubMed Athanasiadis G, Esteban E, Via M, Dugoujon JM, Moschonas N, Chaabani H, Moral P (2007) The X chromosome Alu insertions as a tool for human population genetics: data from European and African human groups. Eur J Hum Genet 15(5):578–583. doi:10.​1038/​sj.​ejhg.​5201797 CrossRefPubMed
22.
Zurück zum Zitat Abun-Nasr JM (1987) A history of the Maghrib in the Islamic period. Cambridge University Press, CambridgeCrossRef Abun-Nasr JM (1987) A history of the Maghrib in the Islamic period. Cambridge University Press, CambridgeCrossRef
23.
Zurück zum Zitat Bognar SK, Furac I, Kubat M, Cosovic C, Demarin V (2002) Croatian population data for arylsulfatase a pseudodeficiency-associated mutations in healthy subjects, and in patients with Alzheimer-type dementia and Down syndrome. Arch Med Res 33(5):473–477 pii:S0188-4409(02)00392-2 CrossRefPubMed Bognar SK, Furac I, Kubat M, Cosovic C, Demarin V (2002) Croatian population data for arylsulfatase a pseudodeficiency-associated mutations in healthy subjects, and in patients with Alzheimer-type dementia and Down syndrome. Arch Med Res 33(5):473–477 pii:S0188-4409(02)00392-2 CrossRefPubMed
24.
Zurück zum Zitat Chabas A, Castellvi S, Bayes M, Balcells S, Grinberg D, Vilageliu L, Marfany G, Lissens W, Gonzalez-Duarte R (1993) Frequency of the arylsulphatase A pseudodeficiency allele in the Spanish population. Clin Genet 44(6):320–323CrossRefPubMed Chabas A, Castellvi S, Bayes M, Balcells S, Grinberg D, Vilageliu L, Marfany G, Lissens W, Gonzalez-Duarte R (1993) Frequency of the arylsulphatase A pseudodeficiency allele in the Spanish population. Clin Genet 44(6):320–323CrossRefPubMed
25.
Zurück zum Zitat Czartoryska B, Zimowski JG, Bisko M, Gorska D (1996) Arylsulfatase A pseudodeficiency—incidence in Poland. Eur J Hum Genet 4(5):301–303PubMed Czartoryska B, Zimowski JG, Bisko M, Gorska D (1996) Arylsulfatase A pseudodeficiency—incidence in Poland. Eur J Hum Genet 4(5):301–303PubMed
26.
Zurück zum Zitat Hwu WL, Tsai LP, Wang WC, Chuang SC, Wang PJ, Wang TR (1996) Arylsulfatase A pseudodeficiency in Chinese. Hum Genet 97(2):148–149CrossRefPubMed Hwu WL, Tsai LP, Wang WC, Chuang SC, Wang PJ, Wang TR (1996) Arylsulfatase A pseudodeficiency in Chinese. Hum Genet 97(2):148–149CrossRefPubMed
27.
Zurück zum Zitat Nelson PV, Carey WF, Morris CP (1991) Population frequency of the arylsulphatase A pseudo-deficiency allele. Hum Genet 87(1):87–88CrossRefPubMed Nelson PV, Carey WF, Morris CP (1991) Population frequency of the arylsulphatase A pseudo-deficiency allele. Hum Genet 87(1):87–88CrossRefPubMed
29.
Zurück zum Zitat Leistner S, Young E, Meaney C, Winchester B (1995) Pseudodeficiency of arylsulphatase A: strategy for clarification of genotype in families of subjects with low ASA activity and neurological symptoms. J Inherit Metab Dis 18(6):710–716CrossRefPubMed Leistner S, Young E, Meaney C, Winchester B (1995) Pseudodeficiency of arylsulphatase A: strategy for clarification of genotype in families of subjects with low ASA activity and neurological symptoms. J Inherit Metab Dis 18(6):710–716CrossRefPubMed
30.
Zurück zum Zitat Julien CA (1994) Histoire de l’Afrique du Nord: des origines à 1830. Payot Julien CA (1994) Histoire de l’Afrique du Nord: des origines à 1830. Payot
Metadaten
Titel
Determination of arylsulfatase A pseudodeficiency allele and haplotype frequency in the Tunisian population
verfasst von
Nizar Ben Halim
Imen Dorboz
Rym Kefi
Najla Kharrat
Eleonore Eymard-Pierre
Majdi Nagara
Lilia Romdhane
Nissaf Ben Alaya-Bouafif
Ahmed Rebai
Najoua Miladi
Odile Boespflug-Tanguy
Sonia Abdelhak
Publikationsdatum
01.03.2016
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 3/2016
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-015-2417-5

Weitere Artikel der Ausgabe 3/2016

Neurological Sciences 3/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.